Future Fund LLC’s Edwards Lifesciences EW Stock Holding History

Future Fund LLC’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.37M	Buy	26,153 +476	+2%	+$39.9K	0.68%	61
2026 Q1	$2.06M	Buy	25,677 +27	+0.1%	+$2.23K	0.72%	60
2025 Q4	$2.19M	Sell	25,650 -825	-3%	-$67.7K	0.69%	41
2025 Q3	$2.06M	Buy	26,475 +3,890	+17%	+$304K	0.73%	38
2025 Q2	$1.77M	Buy	22,585 +2,373	+12%	+$177K	0.79%	32
2025 Q1	$1.46M	Buy	20,212 +4,314	+27%	+$309K	1.88%	13
2024 Q4	$1.18M	Hold	15,898	–	–	3.36%	11
2024 Q3	$1.07M	Buy	15,898 +4,363	+38%	+$317K	3.1%	16
2024 Q2	$1.04M	Buy	11,535 +8,631	+297%	+$764K	2.61%	17
2024 Q1	$278K	Buy	+2,904	New	+$244K	2.25%	24

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Future Fund LLC's EW Position: Q2 2026 in Review

Future Fund LLC increased its Edwards Lifesciences (EW) stake by 1.9% in Q2 2026, buying an estimated $39.9K and bringing the position to 26,153 shares worth $2.37M. The position accounts for 0.68% of the portfolio, ranked #61.

Future Fund LLC first reported a position in EW in Q1 2024 and has held it in 10 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Future Fund LLC held 26,153 shares of Edwards Lifesciences worth $2.37M as of Q2 2026.
Future Fund LLC bought 476 Edwards Lifesciences shares in Q2 2026, an estimated $39.9K.
Edwards Lifesciences made up 0.68% of Future Fund LLC's portfolio in Q2 2026, its #61 holding.
Future Fund LLC first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 10 quarters since.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Future Fund LLC's 13F filing for Q2 2026, filed 12 Aug 2026.